Search





Search





Markets
/
Stocks
/
fulc
/

Fulcrum Therapeutics Inc

FULC

Add to Watchlist

3.725USD

-0.005-0.13%

Close 07-28 16:00（ET）Quotes delayed by 15 min

248.01MMarket Cap

LossP/E TTM

Fulcrum Therapeutics Inc

3.725

-0.005-0.13%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

FULC Cash Flow Statement

You can access the annual and quarterly cash flow statements of Fulcrum Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-22.89%-18.75M

-0.22%-16.80M

25.60%-14.19M

-123.46%-13.82M

39.66%-15.26M

27.62%-16.76M

16.74%-19.07M

383.37%58.90M

-4.84%-25.28M

-17.58%-23.16M

17.85%-22.91M

24.05%-20.79M

-9.09%-24.12M

9.89%-19.70M

-23.52%-27.88M

-53.56%-27.37M

-36.24%-22.11M

-10.25%-21.86M

-401.18%-22.57M

-26.20%-17.82M

-6.72%-16.23M

-341.07%-19.83M

65.40%-4.50M

-16.95%-14.12M

-53.62%-15.20M

29.80%-4.50M

-215.95%-13.02M

-123.30%-12.07M

-49.23%-9.90M

---6.40M

---4.12M

---5.41M

---6.63M

Net income from continuing operations

-7.00%-18.89M

-22.73%-20.33M

9.68%-19.59M

-131.22%-17.30M

34.29%-17.66M

33.07%-16.57M

9.66%-21.70M

332.98%55.41M

-8.44%-26.87M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-11.29%-26.14M

-14.59%-23.74M

-73.40%-34.07M

-52.53%-25.93M

-32.53%-23.48M

-9.25%-20.72M

-25.27%-19.65M

7.87%-17.00M

-9.91%-17.72M

-14.63%-18.96M

-19.11%-15.69M

49.92%-18.45M

-82.00%-16.12M

-84.97%-16.54M

-67.84%-13.17M

-430.88%-36.84M

---8.86M

---8.94M

---7.85M

---6.94M

Operating gains losses

-4.25%338.00K

-5.96%347.00K

-6.23%346.00K

-8.51%344.00K

-26.30%353.00K

-27.36%369.00K

-30.51%369.00K

-33.69%376.00K

-15.37%479.00K

-14.04%508.00K

-13.09%531.00K

-16.12%567.00K

5.60%566.00K

-4.83%591.00K

-1.29%611.00K

0.60%676.00K

-11.11%536.00K

-15.28%621.00K

11.73%619.00K

21.52%672.00K

11.87%603.00K

41.23%733.00K

7.36%554.00K

7.59%553.00K

6.94%539.00K

1.96%519.00K

12.42%516.00K

153.20%514.00K

189.66%504.00K

--509.00K

--459.00K

--203.00K

--174.00K

Other non-cash items

14.68%-767.00K

59.47%-383.00K

49.13%-586.00K

4.32%-1.08M

22.57%-899.00K

28.84%-945.00K

27.32%-1.15M

33.76%-1.13M

15.01%-1.16M

-120.97%-1.33M

-1515.18%-1.58M

-694.44%-1.71M

-486.97%-1.37M

-255.70%-601.00K

21.74%112.00K

138.02%288.00K

377.03%353.00K

1002.86%386.00K

641.18%92.00K

395.12%121.00K

264.44%74.00K

--35.00K

---17.00K

---41.00K

-100.18%-45.00K

--0.00

--25.59M

----

--0.00

Change in working capital

-1375.34%-3.29M

124.16%506.00K

657.32%2.29M

1497.92%1.34M

86.47%-223.00K

-103.10%-2.09M

73.92%-410.00K

-112.31%-96.00K

40.93%-1.65M

-132.43%-1.03M

80.88%-1.57M

-72.74%780.00K

-205.25%-2.79M

200.16%3.18M

-57.29%-8.22M

289.22%2.86M

53.77%-914.00K

30.26%-3.17M

-143.03%-5.23M

-31.25%-1.51M

-286.33%-1.98M

-146.27%-4.55M

563.66%12.14M

-212.20%-1.15M

3436.67%1.06M

729.96%9.84M

-52.57%1.83M

-120.80%-369.00K

110.17%30.00K

--1.19M

--3.86M

--1.77M

---295.00K

-Change in receivables

-100.00%0.00

100.00%0.00

141.96%979.00K

108.01%1.12M

3527.91%1.56M

-1840.79%-1.32M

-318.85%-2.33M

313.08%537.00K

-92.51%43.00K

-74.41%76.00K

-86.91%-557.00K

-95.41%130.00K

123.25%574.00K

158.12%297.00K

-138.40%-298.00K

41.82%2.83M

-27.33%-2.47M

-413.50%-511.00K

70.93%-125.00K

715.08%2.00M

---1.94M

--163.00K

---430.00K

---325.00K

----

-Change in prepaid expenses

-109.77%-179.00K

121.26%44.00K

101.82%44.00K

-162.20%-288.00K

128.14%1.83M

66.72%-207.00K

-250.29%-2.42M

-39.40%463.00K

253.83%803.00K

-181.20%-622.00K

27.99%-692.00K

1176.06%764.00K

-643.75%-522.00K

75.69%766.00K

58.98%-961.00K

-123.13%-71.00K

-93.45%96.00K

1.63%436.00K

-6.26%-2.34M

-38.60%307.00K

153.20%1.47M

68.24%429.00K

-16.91%-2.21M

188.65%500.00K

319.32%579.00K

2418.18%255.00K

-188700.00%-1.89M

-205.42%-564.00K

53.27%-264.00K

---11.00K

--1.00K

--535.00K

---565.00K

-Change in other current assets

---8.00K

-901.52%-529.00K

-99.84%3.00K

-100.00%-2.00K

-100.00%0.00

414.29%66.00K

38160.00%1.91M

-102.78%-1.00K

-68.92%23.00K

-250.00%-21.00K

-28.57%5.00K

102.79%36.00K

127.01%74.00K

73.91%-6.00K

-41.67%7.00K

-4128.13%-1.29M

-1926.67%-274.00K

-160.53%-23.00K

102.22%12.00K

966.67%32.00K

175.00%15.00K

--38.00K

-195.41%-540.00K

100.57%3.00K

68.25%-20.00K

-100.00%0.00

3244.44%566.00K

-5330.00%-523.00K

-325.00%-63.00K

--2.00K

---18.00K

--10.00K

--28.00K

-Change in other current liabilities

-11.43%-195.00K

-10.80%-195.00K

-12.07%-195.00K

-11.25%-178.00K

7.89%-175.00K

66.35%-176.00K

52.72%-174.00K

59.70%-160.00K

47.37%-190.00K

15.65%-523.00K

34.05%-368.00K

69.18%-397.00K

78.55%-361.00K

58.64%-620.00K

85.72%-558.00K

66.47%-1.29M

61.41%-1.68M

16.54%-1.50M

-135.07%-3.91M

-188.36%-3.84M

-753.42%-4.36M

-118.12%-1.80M

13053.49%11.14M

-553.06%-1.33M

-640.58%-511.00K

736.62%9.91M

-102.69%-86.00K

-38.24%294.00K

-114.50%-69.00K

--1.19M

--3.20M

--476.00K

Cash from non-recurring investing activities

Cash from operating activities

-22.89%-18.75M

-0.22%-16.80M

25.60%-14.19M

-123.46%-13.82M

39.66%-15.26M

27.62%-16.76M

16.74%-19.07M

383.37%58.90M

-4.84%-25.28M

-17.58%-23.16M

17.85%-22.91M

24.05%-20.79M

-9.09%-24.12M

9.89%-19.70M

-23.52%-27.88M

-53.56%-27.37M

-36.24%-22.11M

-10.25%-21.86M

-401.18%-22.57M

-26.20%-17.82M

-6.72%-16.23M

-341.07%-19.83M

65.40%-4.50M

-16.95%-14.12M

-53.62%-15.20M

29.80%-4.50M

-215.95%-13.02M

-123.30%-12.07M

-49.23%-9.90M

---6.40M

---4.12M

---5.41M

---6.63M

Investing cash flow

Net cash from continuing investing activities

--8.00K

-31.17%159.00K

373.68%90.00K

--65.00K

-100.00%0.00

200.00%231.00K

-70.77%19.00K

-100.00%0.00

-83.63%28.00K

-33.62%77.00K

-77.03%65.00K

-85.20%195.00K

-30.49%171.00K

-77.65%116.00K

-22.89%283.00K

133.27%1.32M

-6.11%246.00K

9.96%519.00K

294.62%367.00K

169.05%565.00K

-53.79%262.00K

337.04%472.00K

-56.54%93.00K

-4.98%210.00K

82.90%567.00K

-96.88%108.00K

-76.89%214.00K

-94.19%221.00K

-60.41%310.00K

--3.47M

--926.00K

--3.81M

--783.00K

Capital expenditures

--8.00K

-31.17%159.00K

373.68%90.00K

--65.00K

-100.00%0.00

200.00%231.00K

-70.77%19.00K

-100.00%0.00

-83.63%28.00K

-33.62%77.00K

-77.03%65.00K

-85.20%195.00K

-30.49%171.00K

-77.65%116.00K

-22.89%283.00K

133.27%1.32M

-6.11%246.00K

9.96%519.00K

294.62%367.00K

169.05%565.00K

-53.79%262.00K

337.04%472.00K

-56.54%93.00K

-4.98%210.00K

82.90%567.00K

-96.88%108.00K

-76.89%214.00K

-94.19%221.00K

-60.41%310.00K

--3.47M

--926.00K

--3.81M

--783.00K

Net cash flow from disposal of fixed assets

--8.00K

-31.17%159.00K

373.68%90.00K

--65.00K

-100.00%0.00

200.00%231.00K

-70.77%19.00K

-100.00%0.00

-83.63%28.00K

-33.62%77.00K

-77.03%65.00K

-85.20%195.00K

-30.49%171.00K

-77.65%116.00K

-22.89%283.00K

133.27%1.32M

-6.11%246.00K

9.96%519.00K

294.62%367.00K

169.05%565.00K

-53.79%262.00K

337.04%472.00K

-56.54%93.00K

-4.98%210.00K

82.90%567.00K

-96.88%108.00K

-76.89%214.00K

-94.19%221.00K

-60.41%310.00K

--3.47M

--926.00K

--3.81M

--783.00K

Net cash flow from business transactions

----

100.00%0.00

--0.00

---91.00K

----

--0.00

Net cash flow from investment products

-16399.61%-128.20M

-135.73%-890.00K

328.06%18.70M

211.91%14.00M

-102.04%-777.00K

-86.48%2.49M

-77.11%4.37M

-162.32%-12.51M

140.69%38.16M

150.85%18.43M

1056.16%19.09M

-38.65%20.07M

-571.09%-93.77M

-322.69%-36.25M

98.12%-2.00M

226.85%32.71M

57.02%19.91M

39.30%-8.57M

-849.27%-106.27M

-161081.25%-25.79M

122.70%12.68M

---14.13M

--14.18M

---16.00K

---55.84M

----

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-16400.64%-128.21M

-146.42%-1.05M

327.86%18.61M

211.39%13.93M

-102.04%-777.00K

-87.69%2.26M

-77.13%4.35M

-162.93%-12.51M

140.59%38.13M

150.48%18.35M

934.58%19.02M

-36.69%19.88M

-577.85%-93.94M

-299.85%-36.36M

97.86%-2.28M

219.13%31.39M

58.35%19.66M

37.70%-9.09M

-856.82%-106.64M

-11561.06%-26.35M

122.01%12.41M

-13416.67%-14.60M

6684.11%14.09M

-2.26%-226.00K

-13965.84%-56.40M

96.88%-108.00K

76.89%-214.00K

94.19%-221.00K

48.79%-401.00K

---3.47M

---926.00K

---3.81M

---783.00K

Financing cash flow

Cash flow from continuous financing activities

---312.00K

202673.49%168.30M

-89.92%64.00K

-20.16%301.00K

-100.00%0.00

-71.08%83.00K

--635.00K

165.49%377.00K

-98.60%1.65M

31.65%287.00K

-100.00%0.00

-94.95%142.00K

33719.83%117.69M

-75.53%218.00K

-41.30%80.95M

1244.98%2.81M

-99.27%348.00K

-85.76%891.00K

166248.19%137.90M

-99.68%209.00K

17237.23%47.50M

2325.98%6.25M

-100.13%-83.00K

12327.98%64.69M

682.98%274.00K

-212.22%-281.00K

-18.32%65.20M

-104.18%-529.00K

-100.37%-47.00K

---90.00K

--79.83M

--12.65M

--12.64M

Net cash flow from debt Issuance/repayment

----

100.00%0.00

--0.00

100.00%0.00

92.31%-1.00K

----

58.33%-5.00K

-8.33%-13.00K

-18.18%-13.00K

0.00%-13.00K

-20.00%-12.00K

-9.09%-12.00K

0.00%-11.00K

-30.00%-13.00K

-42.86%-10.00K

73.81%-11.00K

---11.00K

---10.00K

---7.00K

---42.00K

Net cash flow from common stock issuance/repurchase

--21.00K

202673.49%168.30M

-89.92%64.00K

-20.16%301.00K

-100.00%0.00

-71.08%83.00K

--635.00K

165.49%377.00K

-98.60%1.65M

31.65%287.00K

-100.00%0.00

-94.95%142.00K

33719.83%117.69M

-75.56%218.00K

-41.30%80.95M

1116.88%2.81M

-99.27%348.00K

-85.77%892.00K

197102.86%137.90M

-99.64%231.00K

16514.34%47.52M

--6.27M

-325.81%-70.00K

29666.51%64.89M

14400.00%286.00K

100.00%0.00

3000.00%31.00K

--218.00K

-111.76%-2.00K

---6.00K

--1.00K

--0.00

--17.00K

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

--79.76M

--0.00

--12.66M

Net cash flow from other financing activities

---333.00K

----

--0.00

----

--1.00K

91.19%-17.00K

----

100.00%0.00

-100.00%0.00

73.81%-193.00K

----

99.66%-270.00K

-18.35%65.18M

---737.00K

---34.00K

---79.83M

--79.83M

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

---312.00K

202673.49%168.30M

-89.92%64.00K

-20.16%301.00K

-100.00%0.00

-71.08%83.00K

--635.00K

165.49%377.00K

-98.60%1.65M

31.65%287.00K

-100.00%0.00

-94.95%142.00K

33719.83%117.69M

-75.53%218.00K

-41.30%80.95M

1244.98%2.81M

-99.27%348.00K

-85.76%891.00K

166248.19%137.90M

-99.68%209.00K

17237.23%47.50M

2325.98%6.25M

-100.13%-83.00K

12327.98%64.69M

682.98%274.00K

-212.22%-281.00K

-18.32%65.20M

-104.18%-529.00K

-100.37%-47.00K

---90.00K

--79.83M

--12.65M

--12.64M

Net cash flow

Beginning cash balance

234.50%198.73M

-34.61%48.28M

-50.19%43.79M

5.42%43.38M

122.90%59.41M

136.85%73.83M

150.78%87.92M

14.86%41.15M

-26.35%26.66M

-66.13%31.17M

-15.00%35.06M

4.13%35.83M

-0.86%36.19M

38.26%92.03M

-28.73%41.24M

-66.22%34.41M

-37.22%36.50M

-22.88%66.56M

-24.66%57.87M

284.71%101.84M

-40.55%58.14M

-15.95%86.31M

51.44%76.81M

-58.34%26.47M

32.37%97.81M

22.47%102.69M

459.27%50.72M

1028.27%63.54M

18054.55%73.89M

--83.85M

--9.07M

--5.63M

--407.00K

Current period cash flow changes

-818.50%-147.27M

1143.52%150.46M

131.84%4.49M

-99.11%414.00K

-210.62%-16.03M

-219.19%-14.42M

-262.51%-14.09M

6189.58%46.77M

4082.14%14.49M

91.91%-4.52M

-107.65%-3.89M

-111.23%-768.00K

82.66%-364.00K

-85.76%-55.84M

484.14%50.78M

115.56%6.84M

-104.80%-2.10M

-6.72%-30.06M

-8.51%8.69M

-187.34%-43.97M

161.25%43.69M

-476.76%-28.17M

-81.71%9.50M

492.54%50.34M

-589.55%-71.33M

50.96%-4.88M

-30.50%51.97M

-473.12%-12.82M

-297.99%-10.35M

---9.96M

--74.78M

--3.44M

--5.22M

Ending cash balance

18.63%51.46M

234.50%198.73M

-34.61%48.28M

-50.19%43.79M

5.42%43.38M

122.90%59.41M

136.85%73.83M

150.78%87.92M

14.86%41.15M

-26.35%26.66M

-66.13%31.17M

-15.00%35.06M

4.13%35.83M

-0.86%36.19M

38.26%92.03M

-28.73%41.24M

-66.22%34.41M

-37.22%36.50M

-22.88%66.56M

-24.66%57.87M

284.71%101.84M

-40.55%58.14M

-15.95%86.31M

51.44%76.81M

-58.34%26.47M

32.37%97.81M

22.47%102.69M

459.27%50.72M

1028.27%63.54M

--73.89M

--83.85M

--9.07M

--5.63M

Free cash flow

-22.95%-18.76M

0.21%-16.96M

25.20%-14.28M

-123.57%-13.88M

39.72%-15.26M

26.87%-16.99M

16.89%-19.09M

380.74%58.90M

-4.22%-25.31M

-17.28%-23.23M

18.44%-22.97M

26.86%-20.98M

-8.66%-24.29M

11.46%-19.81M

-22.78%-28.16M

-56.01%-28.68M

-35.57%-22.35M

-10.24%-22.38M

-399.02%-22.94M

-28.30%-18.39M

-4.55%-16.49M

-340.97%-20.30M

65.26%-4.60M

-16.56%-14.33M

-54.51%-15.77M

53.36%-4.60M

-162.21%-13.23M

-33.45%-12.29M

-37.65%-10.21M

---9.87M

---5.05M

---9.21M

---7.42M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Fulcrum Therapeutics Inc Generate?



Fulcrum Therapeutics Inc generated -60.06M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Fulcrum Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Fulcrum Therapeutics Inc's operating cash flow increased by -2608.07% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Fulcrum Therapeutics Inc Spend on Capital Expenditures?



Fulcrum Therapeutics Inc spent 314.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Fulcrum Therapeutics Inc's Financing Cash Flow Changed?



Fulcrum Therapeutics Inc used 168.67M in financing activities in the latest quarter.

What is free cash flow and why does it matter for FULC?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Fulcrum Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -60.38M reflecting a -2319.03% change from the previous year.